Literature DB >> 2982236

Purification and chemical and immunological characterization of avian reticuloendotheliosis virus gag-gene-encoded structural proteins.

W P Tsai, T D Copeland, S Oroszlan.   

Abstract

Five gag-gene-encoded structural proteins, designated p12, pp18, pp20, p30, and p10 were purified from replication-competent avian reticuloendotheliosis-associated virus (REV-A) by high-performance liquid chromatography complemented with chloroform-methanol extraction and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Based on amino acid composition and NH2- and COOH-terminal sequence analysis p12, pp18, p30, and p10 are distinct from one another, whereas pp20 is likely identical to pp18 in primary structure. The p12 was resistant to Edman degradation and was found to be myristylated at the NH2-terminal amino group. Sequence comparisons among the retrovirus family show that pp18/pp20 and p10 are, respectively, homologs of phospho-proteins and nucleic acid-binding proteins. A comparison of terminal sequences with the nucleotide sequence of spleen necrosis virus (SNV) revealed that the gag genes of SNV and REV-A are highly conserved; together with the identification of REV-A gag-precursor polyprotein, Pr60gag in immunoprecipitates of radiolabeled cell lysates, this comparison also led to the establishment of the organization of Pr60gag, viz., NH2-p12-pp18-p30-p10-OH. Sequence comparisons show that REV-A/SNV is related to mammalian type C viruses: the pp18-p30 region is most homologous to the macaque/colobus group and least to simian sarcoma virus (SSV), whereas both the 5'- and 3'-gag regions (i.e., p12 and p10) are clostest to SSV. Immunological studies using monospecific antisera and Western-blot analysis showed that antigenic determinants of REV-A p30 are conserved in most of mammalian type C and type D viruses, but those of REV-A p12 are shared only with simian sarcoma-associated virus (SSAV) and endogenous viruses of macaques.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982236     DOI: 10.1016/0042-6822(85)90367-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells.

Authors:  C R Erdie; J W Wills
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Localization of the v-rel protein in reticuloendotheliosis virus strain T-transformed lymphoid cells.

Authors:  S L Simek; R M Stephens; N R Rice
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

3.  Novel glycosylation pathways of retroviral envelope proteins identified with avian reticuloendotheliosis virus.

Authors:  W P Tsai; S Oroszlan
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing.

Authors:  T A Weaver; K J Talbot; A T Panganiban
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA.

Authors:  J L Certo; B F Shook; P D Yin; J T Snider; W S Hu
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens.

Authors:  J G Calvert; K Nazerian; R L Witter; N Yanagida
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Reticuloendotheliosis type C and primate type D oncoretroviruses are members of the same receptor interference group.

Authors:  H M Koo; J Gu; A Varela-Echavarria; Y Ron; J P Dougherty
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.

Authors:  Zahida Parveen; Muhammad Mukhtar; Adrienne Goodrich; Edward Acheampong; Ralph Dornburg; Roger J Pomerantz
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Complete Genome Sequence of Reticuloendotheliosis Virus Strain MD-2, Isolated from a Contaminated Turkey Herpesvirus Vaccine.

Authors:  Junping Li; Chenghuai Yang; Qihong Li; Huijiao Li; Yecai Xia; Dan Liu; Kangzhen Yu; Hanchun Yang
Journal:  Genome Announc       Date:  2013-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.